Healthy Trials in Fargo, United States
Conditions / Healthy / Fargo, United States
Healthy is a medical condition with active clinical research programs worldwide.
145 total trials for this combination
Showing top 10 of 145 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00960323 | Drug-Drug Interaction Study Between Colchicine and Atorvastatin | COMPLETED | PHASE1 |
| NCT01396590 | Demonstrate Bioequivalence Between 6 ? 2-mg Tablets of Perampanel and a Single 12-mg Tablet of Perampanel in Healthy Subjects | COMPLETED | PHASE1 |
| NCT00983931 | Drug-Drug Interaction Study Between Colchicine and Cyclosporine | COMPLETED | PHASE1 |
| NCT01191723 | QT Intervals Study to Compare the Acute Effects of Orally Inhaled Dihydroergotamine (DHE), Oral Moxifloxacin, and Placebo | COMPLETED | PHASE1 |
| NCT01396577 | Demonstrate Bioequivalence Between 3 x 2-mg Tablets of Perampanel and a Single 6-mg Tablet of Perampanel in Healthy Subjects | COMPLETED | PHASE1 |
| NCT00964730 | A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm | COMPLETED | PHASE1 |
| NCT01430312 | 21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation | COMPLETED | PHASE1 |
| NCT01282684 | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PLX5622 in Healthy Adult Volunteers | COMPLETED | PHASE1 |
| NCT01430533 | Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation | COMPLETED | PHASE1 |
| NCT02508753 | Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Dose, on the QT/QTc Intervals in Healthy Subjects | COMPLETED | PHASE1 |